Efficacy of Mindfulness-based Stress Reduction in Hemodialysis Patients with Anxiety and Depression
a randomized, double-blind, parallel-group trial
Keywords:
Mindfulness, Anxiety, Depression, Renal dialysisAbstract
Background: Diseases with a chronic and debilitating nature, such as chronic kidney disease, are frequently associated with psychiatric disorders like anxiety and depression. Objective: To assess the efficacy of mindfulness-based stress reduction (MBSR) on anxiety and depression in hemodialysis patients. Methods: In this randomized clinical trial, fifty hemodialysis patients were selected from two dialysis centers of Kashan city in Iran in 2016. The patients had desired cognitive status based on MMSE (Mini Mental Status Examination) and clinical interview, and were randomly allocated into the intervention and control groups. The intervention group (n=25) received a Mindfulness-Based Stress Reduction (MBSR) program in addition to the health education program in eight sessions, whereas the control group (n=25) received only the health education program. To measure the anxiety and depression score before and after study, the Hospital Anxiety and Depression Scale were used. Data were analyzed by SPSS version 11.5, using Analysis of Covariance (ANCOVA), t-test, Chi-square, Mann-Whitney U, and Fisher exact test. Results: The mean age of intervention and control groups were 46.86±11.66 and 46.26±11.71 respectively. The mean duration of illness was 2.47±1.78 and 2.62±1.32 in intervention and control groups respectively. There were no significant differences between the two groups regarding age, sex, education level and job. Depression and anxiety were reduced in the intervention group compared with the control group (p=0.0001). Conclusions: The MBSR program may reduce anxiety and depression in hemodialysis patients. Funding: This study was financially supported by the Deputy of Research, Kashan University of Medical Sciences, Kashan, Iran (Ref: 9436). Clinical Trial Registration: The protocol of study was registered at the Iranian Registry of Clinical Trials (IRCT) with ID number of IRCT2015081723652N1.References
McCullough K, Sharma P, Ali T, Smith WC, MacLeod A, Black C. Measuring the population burden ofchronic kidney disease: a systematic literature review of the estimated prevalence of impaired kidneyfunction. Nephrol Dial Transplant. 2011; 27(5): 1812-21. doi: 10.1093/ndt/gfr547. PMID: 21965592.
Mousavi SS, Soleimani A, Mousavi MB. Epidemiology of end-stage renal disease in Iran: a review article.Saudi J Kidney Dis Transpl. .2014; 25(3): 697-702. PMID: 24821181
Mokhtari N, Nasiri M, Mashuuf T, Kazemnejad E. Comparative study of hemodialysis patients’ QOL frompatients’ and nurses’ perception. Journal of Guilan University of Medical Sciences. 2003; 12(47): 16-23.
Zamanzadeh V, Heidarzadeh M, Oshvandi KH, Lakdizaji S. Relationship between quality of life and socialsupport in hemodialysis patients in Imam Khomeini and Sina educational hospitals of Tabriz University ofmedical sciences. Medical Journal of Tabriz University of Medical Sciences. 2007; 29(1): 49-54.
Levey AS, Coresh J. Chronic kidney disease. Lancet. 2012; 379: 165-80.
Pakpour A, Panahi CH, Yekaninejad M, Ebadi Fard Azar F, Izy H. A comparative study on health relatedquality of life in hemodialysis patients and healthy people. Journal of Health Administration. 2006; 9(25):55-62.7)NavidianA, Arbabi Sarjou A, Kikhai A. Frequency of mental disturbances in hemodialysis patientsreferred to hemodialysis ward of khatam-al-anbia hospital in zahedan. Journal of Guilan University ofMedical Sciences. 2006; 15(58): 61-7.8)Nazemian F, GHafari F, Pourghazneyn T. Evaluation of depression and anxiety in hemodialysis patients.Medical journal of mashhad university of medical sciences. 2008; 51(3): 171-6.9)Hedayati SS, Grambow SC, Szczech LA, Stechuchak KM, Allen AS, Bosworth HB. Physician-diagnoseddepression as a correlate of hospitalizations in patients receiving long-term hemodialysis. Am J KidneyDis. 2005; 46(4): 642-9. doi: 10.1053/j.ajkd.2005.07.002. PMID: 16183419.10)Feroze U, Martin D, Reina-Patton A, Kalantar-Zadeh K, Kopple JD. Mental health, depression, and anxietyin patients on maintenance dialysis. Iranian journal of kidney diseases. 2010; 4(3): 173-80.11)Hosseini SH, Espahbodi F, Mirzadeh Goudarzi SM. Citalopram versus psychological training fordepression and anxiety symptoms in hemodialysis patients. Iranian journal of kidney diseases. 2012; 6(6):446-51.12)Stern TA, Freudenreich O, Smith FA, Fricchione GL, Rosenbaum JF. Hanbook of general hospitalpsychiatry. 7th edition. 2018: 306-10.13)Ie A, Ngnoumen CT, Langer EJ. The Wiley Blackwell handbook of mindfulness. John Wiley & Son; 2014.14)Omidi A, Mohammadi A, Zargar F, Akbari H. Efficacy of Mindfulness-Based Stress Reduction on MoodStates of Veterans With Post-Traumatic Stress Disorder. Arch Trauma Res. 2013; 1(4): 151–4.15)Bränström R, Duncan LG, Moskowitz JT .The association between dispositional mindfulness,psychological well‐being, and perceived health in a Swedish population‐based sample. Br J HealthPsychol. 2011; 16(2): 300-16. doi: 10.1348/135910710X501683. PMID: 21489058, PMCID:PMC3762484.16)Omidi A, ZargarF. Effect of mindfulness-basedstress reduction on pain severity and mindful awareness inpatients with tension headache: a randomized controlled clinical trial. Nurs Midwifery stud. 2014; 3(3):e21136. PMID: 25699282, PMCID: PMC4332994.17)Kolahkaj B, ZargarF. Effect of mindfulness-basedstress reduction on anxiety, depression and stress inwomen with multiple sclerosis. Nursing and midwifery studies. 2015; 4(4): e29655. doi:10.17795/nmsjournal29655. PMID: 26835467, PMCID: PMC4733502.18)Merkes M. Mindfulness-based stress reduction for people with chronic diseases. Aust J Prim Health. 2010;16(3): 200-10. doi: 10.1071/PY09063. PMID: 20815988.19)Parswani MJ, Sharma MP, Iyengar S. Mindfulness-based stress reduction program in coronary heartdisease: A randomized control trial. Int J Yoga. 2013 Jul;6(2):111-7. doi: 10.4103/0973-6131.113405.PMID: 23930029, PMCID: PMC373463620)Montazeri A, Vahdaninia M, Ebrahimi M. The Hospital Anxiety and Depression Scale (HADS): translationand validation study of the Iranian version. Health Qual Life Outcomes. 2003; 1(1): 14. doi: 10.1186/1477-7525-1-14. PMID: 12816545, PMCID: PMC161819.21)Peterson LG, Pbert L. Effectiveness of a meditation-based stress reduction program in the treatment ofanxiety disorders. Am J Psychiatry. 1992; 149(7): 936-43.22)Barnhofer T, CraneC, Hargus E, Amarasinghe M, Winder R, Williams JM. Mindfulness-based cognitivetherapy as a treatment for chronic depression: A preliminary study. Behav Res Ther. 2009; 47(5): 366-73.doi: 10.1016/j.brat.2009.01.019. PMID: 19249017, PMCID: PMC2866254.23)Bohlmeijer E, Prenger R, Taal E, Cuijpers P. The effects of mindfulness-based stress reduction therapy onmental health of adults with a chronic medical disease: a meta-analysis. J Psychosom Res. 2010; 68(6):539-44. doi: 10.1016/j.jpsychores.2009.10.005. PMID: 20488270.24)Speca M, Carlson LE, Goodey E, Angen M. A randomized, wait-list controlled clinical trial: the effect of amindfulness meditation-based stress reduction program on mood and symptoms of stress in cancer.Psychosom Med. 2000; 62(5): 613-22. PMID: 11020090
Reibel DK, Greeson JM, Brainard GC, Rosenzweig S. Mindfulness-based stress reduction and health-related quality of life in a heterogeneous patient population. Gen Hosp Psychiatry. 2001; 23(4): 183-192.doi: 10.1016/S0163-8343(01)00149-9. PMID:11543844.26)Miller JJ, Fletcher K, Kabat-Zinn J. Three-year follow-up and clinical implications of a mindfulnessmeditation-based stress reduction intervention in the treatment of anxiety disorders. General hospitalpsychiatry. 1995; 17(3): 192-200. PMID: 764946327)Teasdale JD, Segal ZV, Williams JM, Ridgeway VA, Soulsby JM, Lau MA. Prevention ofrelapse/recurrence in major depression by mindfulness-based cognitive therapy. J Consult Clin Psychol.2000; 68(4): 615-23. PMID: 10965637.28)Reilly-Spong M, Reibel D,Pearson T, Koppa P, Gross CR. Telephone-adapted mindfulness-based stressreduction (tMBSR) for patients awaiting kidney transplantation: Trial design, rationale and feasibility.Contemporary clinical trials. 2015; 42: 169-184. doi: 10.1016/j.cct.2015.03.013. PMID: 25847578,PMCID: PMC4450136.29)Astin JA. Stress reduction through mindfulness meditation. Psychotherapy and psychosomatics. 1997;66(2): 97-106. doi: 10.1159/000289116.30)Williams KA, Kolar MM, Reger BE, Pearson JC. Evaluation of a wellness-based mindfulness stressreduction intervention: A controlled trial. AJHP. 2001; 15(6): 422-432. doi: 10.4278/0890-1171-15.6.422.31)Henderson VP, Clemow L, Massion AO, Hurley TG, Druker S, Hébert JR. The effects of mindfulness-based stress reduction on psychosocial outcomes and quality of life in early-stage breast cancer patients: arandomized trial. Breast Cancer Res Treat. 2012; 131(1): 99-109. doi: 10.1007/s10549-011-1738-1. PMID:21901389, PMCID: PMC3784652.32)Carlson LE, Doll R, Stephen J, Faris P, Tamagawa R, Drysdale E, et al. Randomized-controlled multi-sitetrial of mindfulness-based cancer recovery (MBCR) versus supportive expressive group therapy (SET)among breast cancer survivors (MINDSET): long-term follow-up results. Pscyho-oncology. 2013; 22: 103-104. doi: 10.1200/JCO.2012.47.5210.33)Omidi A, Momeni J, Raygan F, Akbari H, Talighi E. The effectivness of mindfulness-based stressreduction program on quality of life among patients with cardiovascular disease. Journal of Thought andbehavioral in clinical psychology. 2017; 10(24): 7-16.34)Omidi A, Zargar F. Effect of mindfulness-based stress reduction on percived stress and psychologicalhealth in patients with tension headache. JRMS. 2015; 20: 1058-63.35)Kabat-Zinn J. Wherever you go, there you are: Mindfulness meditation in everyday life. New York:Hyperion.36)Gu J, Strauss C, Bond R, Cavanagh K. How do mindfulness-based cognitive therapy and mindfulness-based stress reduction improve mental health and wellbeing? A systematic review and meta-analysis ofmediation studies. Clinical Psychology Review. 1994; 37(2015): 1–12.37)Daividson RJ. Kabat-Zinn J, Schumacher J, Rosenkranz M, Muller D, Santorelli SF, et al. Alteration inbrain and immune function produced by mindfulness meditation. Psychosom Med. 2003; 65: 564-40.PMID: 12883106.38)Lazar SW, Kerr CE, Wasserman RH, Gray JR, Greve DN, Treadway MT, et al. Meditation experience isassociated with increased cortical thickness. Neuroreport. 2005; 16: 1893-7. PMID: 16272874, PMCID:PMC1361002.39)Kimmel PL. Psychosocial factors inadult end-stage renal disease patients treated with hemodialysis:correlates and outcomes. Am J Kidney Dis. 2000; 35(4): S132-40. doi: 10.1016/S0272-6386(00)70240-X.PMID: 10766011
Downloads
Published
Issue
Section
License
Copyright (c) 2020 Knowledge Kingdom Publishing
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
